Home
/
HeartSciences Inc.
/
Financials
/
Quarterly
HeartSciences Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that HeartSciences Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 31, 2026
$0
Mar 16, 2026
Q2
2025
Oct 31, 2025
$2.4K
Dec 15, 2025
Q1
2025
Jul 31, 2025
$1.9K
Sep 11, 2025
Q3
2026
Jan 31, 2025
$0
Mar 16, 2026
Q3
2025
Jan 31, 2024
$14.7K
Mar 13, 2025
Q2
2025
Oct 31, 2023
$3.9K
Dec 16, 2024
Q3
2024
Jan 31, 2023
$2.0K
Mar 14, 2024
Q2
2024
Oct 31, 2022
$3.2K
Dec 14, 2023
Q1
2024
Jul 31, 2022
$3.2K
Sep 14, 2023
Q3
2023
Jan 31, 2022
$2.7K
Mar 16, 2023
Q2
2023
Oct 31, 2021
$7.5K
Dec 15, 2022
Q1
2023
Jul 31, 2021
$7.5K
Sep 12, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 31, 2026
($1.99M)
Mar 16, 2026
Q2
2025
Oct 31, 2025
($2.35M)
Dec 15, 2025
Q1
2025
Jul 31, 2025
($2.05M)
Sep 11, 2025
Q3
2026
Jan 31, 2025
($2.54M)
Mar 16, 2026
Q2
2025
Oct 31, 2024
($2.08M)
Dec 15, 2025
Q1
2025
Jul 31, 2024
($2.05M)
Sep 11, 2025
Q3
2025
Jan 31, 2024
($1.64M)
Mar 13, 2025
Q2
2025
Oct 31, 2023
($1.75M)
Dec 16, 2024
Q1
2025
Jul 31, 2023
($1.37M)
Sep 12, 2024
Q3
2024
Jan 31, 2023
($1.34M)
Mar 14, 2024
Q2
2024
Oct 31, 2022
($1.81M)
Dec 14, 2023
Q1
2024
Jul 31, 2022
($1.57M)
Sep 14, 2023
Q3
2023
Jan 31, 2022
($1.24M)
Mar 16, 2023
Q2
2023
Oct 31, 2021
($1.03M)
Dec 15, 2022
Q1
2023
Jul 31, 2021
($501.9K)
Sep 12, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 31, 2026
($1.93M)
Mar 16, 2026
Q2
2025
Oct 31, 2025
($2.07M)
Dec 15, 2025
Q1
2025
Jul 31, 2025
($1.87M)
Sep 11, 2025
Q3
2026
Jan 31, 2025
($2.37M)
Mar 16, 2026
Q2
2025
Oct 31, 2024
($1.99M)
Dec 15, 2025
Q1
2025
Jul 31, 2024
($2.08M)
Sep 11, 2025
Q3
2025
Jan 31, 2024
($1.53M)
Mar 13, 2025
Q2
2025
Oct 31, 2023
($1.57M)
Dec 16, 2024
Q1
2025
Jul 31, 2023
($1.33M)
Sep 12, 2024
Q3
2024
Jan 31, 2023
($1.31M)
Mar 14, 2024
Q2
2024
Oct 31, 2022
($1.77M)
Dec 14, 2023
Q1
2024
Jul 31, 2022
($1.43M)
Sep 14, 2023
Q3
2023
Jan 31, 2022
($1.10M)
Mar 16, 2023
Q2
2023
Oct 31, 2021
($956.9K)
Dec 15, 2022
Q1
2023
Jul 31, 2021
($674.4K)
Sep 12, 2022